Cited by 684Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.

Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

Open access

Martin, Lee J., Pan, Yan, Price, Ann C., Sterling, Wanda, Copeland, Neal G., Jenkins, Nancy A., Price, Donald L., Lee, Michael K.·2006·The Journal of Neuroscience

DOI 10.1523/jneurosci.4308-05.2006PMC PMC6381830

Open this paper in CoChat — free account Open PDF

Abstract

α-Synuclein (α-Syn) is enriched in nerve terminals. Two mutations in the α-Syn gene (Ala53→ Thr and Ala30→ Pro) occur in autosomal dominant familial Parkinson's disease. Mice overexpressing the human A53T mutant α-Syn develop a severe movement disorder, paralysis, and synucleinopathy, but the mechanisms are not understood. We examined whether transgenic mice expressing human wild-type or familial Parkinson's disease-linked A53T or A30P mutant α-syn develop neuronal degeneration and cell death. Mutant mice were examined at early- to mid-stage disease and at near end-stage disease. Age-matched nontransgenic littermates were controls. In A53T mice, neurons in brainstem and spinal cord exhibited large axonal swellings, somal chromatolytic changes, and nuclear condensation. Spheroid eosinophilic Lewy body-like inclusions were present in the cytoplasm of cortical neurons and spinal motor neurons. These inclusions contained human α-syn and nitrated synuclein. Motor neurons were depleted (∼75%) in A53T mice but were affected less in A30P mice. Axonal degeneration was present in many regions. Electron microscopy confirmed the cell and axonal degeneration and revealed cytoplasmic inclusions in dendrites and axons. Some inclusions were degenerating mitochondria and were positive for humanα-syn. Mitochondrial complex IV and V proteins were at control levels, but complex IV activity was reduced significantly in spinal cord. Subsets of neurons in neocortex, brainstem, and spinal cord ventral horn were positive for terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling, cleaved caspase-3, and p53. Mitochondria in neurons had terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling-positive matrices and p53 at the outer membrane. Thus, A53T mutant mice develop intraneuronal inclusions, mitochondrial DNA damage and degeneration, and apoptotic-like death of neocortical, brainstem, and motor neurons.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4308-05.2006

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 1×
“p53 can mediate mitochondrial membrane permeabilization and apoptosis by activating Bax and Bak (Chipuk et al., 2004; Leu et al., 2004).”
Background
Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative Disorders
Masliah, E., Rockenstein, E. M., Veinbergs, I., Mallory, M. E., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,779
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S. H., Zaika, A. I., Petrenko, O., Chittenden, T. D., Pančoška, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,771
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646
Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy Lesions
Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,567
Alpha-synuclein and neurodegenerative diseases
Goedert, M. (2001) · Nature reviews. Neuroscience · doi:10.1038/35081564 · Cited by 1,428

Show all 59 references

Research works printed but not linked: 6

Chayen J, Bitensky L, Butcher R (1973) Practical histochemistry. New York: Wiley.
2001, Int J Mol Med, 7, 455
2002, J Neurobiol, 5, 181
2002, Neurochem Res, 27, 1089
1997, J Comp Neurol, 378, 70
2000, J Biol Chem, 265, 18344

Sorted by citations

Items 501–600 of 684

Alpha-synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s diseasePreprint
Cole, T. A., Zhao, H. T., Collier, T. J., Sandoval, I. M., Sortwell, C. E., Steece‐Collier, K., Daley, B. F., Booms, A., Lipton, J. W., Welch, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/830554 · Cited by 10
Parkinson's Disease and Mitotherapy-Based Approaches towards α-Synucleinopathies
Bhatt, V., Shukla, H., & Tiwari, A. K. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2306109 · Cited by 9
Surgical Management of Synucleinopathies
Sriram, S., Root, K. T., Chacko, K. M., Patel, A., & Lucke-Wold, B. P. (2022) · Biomedicines · doi:10.3390/biomedicines10102657 · Cited by 9
Association between use of ß2-adrenergic receptor agonists and incidence of Parkinson’s disease: Retrospective cohort analysis
Nadeem, H., Zhou, B., Goldman, D. P., & Romley, J. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276368 · Cited by 10
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
Chen, X., Tsika, E., Levine, N. D., & Moore, D. J. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00641-4 · Cited by 10
α-Synuclein A53T Promotes Mitochondrial Proton Gradient Dissipation and Depletion of the Organelle Respiratory Reserve in a Neuroblastoma Cell Line
Risiglione, P., Cubisino, S. A. M., Lipari, C. L. R., Pinto, V. D., Messina, A. A., & Magrì, A. (2022) · Life · doi:10.3390/life12060894 · Cited by 9
Dietary Phytochemicals in Neurodegenerative Disease
Jacquet, A. D. R., Tambe, M. A., & Rochet, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802928-2.00018-7 · Cited by 8
Lysosome‐Acidifying Nanoparticles Rescue A30P α‐Synuclein Induced Neuronal Death in Cellular and Drosophila Models of Parkinson's Disease
Lo, C. H., Ren, M., Loi, G. W. Z., Saipuljumri, E. N., Indajang, J., Lim, K., & Zeng, J. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202502906 · Cited by 8
LRRK2G2019S Gene Mutation Causes Skeletal Muscle Impairment in Animal Model of Parkinson's Disease
Hu, Y., Yang, H., Song, C., Tian, L., Wang, P., Li, T., Cheng, C., Al‐Nusaif, M., Li, S., Liang, Z., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13604 · Cited by 8
Mitochondrial Fission and Fusion
Hewitt, V. L., & Whitworth, A. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00003-1 · Cited by 10
A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson’s disease by highlighting the use of cybrid models
Lang, M., Grünewald, A., Pramstaller, P. P., Hicks, A. A., & Pichler, I. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04304-3 · Cited by 8
Establishment of Stably Transfected Rat Neuronal Cell Lines Expressing α-Synuclein GFP Fusion Proteins
Schwach, G., Tschemmernegg, M., Pfragner, R., Ingolić, E., Schreiner, E., & Windisch, M. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9289-1 · Cited by 8
Alpha-synuclein and Parkinson disease
LIU, H. (2007) · Neural Regeneration Research · doi:10.1016/s1673-5374(07)60053-x · Cited by 8
Mitochondria and Parkinson's Disease
Simon, D. K., Chu, C. T., & Swerdlow, R. H. (2011) · Parkinson s Disease · doi:10.4061/2011/261791 · Cited by 8
Intracellular A53T Mutant α-Synuclein Impairs Adult Hippocampal Newborn Neuron Integration
Regensburger, M., Stemick, J., Masliah, E., Kohl, Z., & Winner, B. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.561963 · Cited by 8
Mitochondrial Medicine: The Central Role of Cellular Energetic Depression and Mitochondria in Cell Pathophysiology
Seppet, E. K., Gizatullina, Z. Z., Trumbeckaitė, S., Zierz, S., Striggow, F., & Gellerich, F. N. (2007) · Wiley eBooks · doi:10.1002/9783527621095.ch15 · Cited by 8
The role of gasotransmitters in Parkinson's disease: Interplay of nitric oxide, carbon monoxide, and hydrogen sulfide
O'Connor, J. L., Fountos, D. M., Firouzan, B., Azizi, F., Ghasemi, R., & Kashfi, K. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00710 · Cited by 8
Molecular Mechanisms of Dopaminergic Neuron Degeneration in Parkinson’s Disease: A Comprehensive Review
Abubakar, M., Alom, S., Ali, F., Ali, S. R., Adhikary, K., Sarika, S., Gupta, P. K., Puppala, E. R., Murti, K., Nand, S., et al. (2026) · Current Neuropharmacology · doi:10.2174/011570159x446831260303200516 · Cited by 7
Experimental Parkinson models and green chemistry approach
AKYAZI, Ö., Korkmaz, D., & Cevher, Ş. C. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115092 · Cited by 7
Circadian regulation and its disorders in Parkinson’s disease patients. Part 2: Experimental models, alpha-synuclein, and melatonin
Ukraintseva, Y. V., & Kovalzon, V. M. (2016) · Human Physiology · doi:10.1134/s0362119716050170 · Cited by 7
Integrated analysis of genetic, behavioral, and biochemical data implicates neural stem cell-induced changes in immunity, neurotransmission and mitochondrial function in Dementia with Lewy Body mice
Lakatos, A., Goldberg, N. R. S., & Blurton-Jones, M. M. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0421-0 · Cited by 8
Monitoring of a progressive functional dopaminergic deficit in the A53T-AAV synuclein rats by combining 6-[18F]fluoro-L-m-tyrosine imaging and motor performances analysis
Becker, G., Michel, A., Bahri, M. A., Mairet‐Coello, G., Lemaire, C. F., Deprez, T., Freyssin, A., Jacquin, L., Hustadt, F., Wolf, C. D., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.07.012 · Cited by 7
Adeno-associated virus-delivered alpha synuclein inhibits bladder cancer growth via the p53/p21 signaling pathway
Wu, Z., Xia, C., Zhang, C., Tang, D., Liu, F., Ou, Y., Gao, J., Yi, H., Yang, D., & Ma, K. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00425-w · Cited by 6
Neurodegeneration in Parkinson’s Disease: Genetics Enlightens Physiopathology
Corti, O., Fournier, M., & Brice, A. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_17 · Cited by 7
Tristetraprolin inhibits mitochondrial function through suppression of α-Synuclein expression in cancer cells
Vo, M., Choi, S. H., Lee, J.-H., Hong, C. H., Kim, J. S., Lee, U. H., Chung, H., Lee, B. J., Park, J. W., & Cho, W. J. (2017) · Oncotarget · doi:10.18632/oncotarget.16706 · Cited by 7
Protein trapping leads to altered synaptic proteostasis in synucleinopathies
Santos, P. I., & Outeiro, T. F. (2020) · FEBS Journal · doi:10.1111/febs.15364 · Cited by 7
Alpha Synuclein and Parkinson’s Disease
Parihar, A., Parihar, P., Solanki, I., & Parihar, M. S. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_1 · Cited by 8
Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits
Keomanivong, C., Schamp, J. H., Tabakovic, E. E., Thangavel, R., Aldridge, G. M., Pieper, A. A., & Narayanan, N. S. (2024) · eNeuro · doi:10.1523/eneuro.0170-23.2023 · Cited by 6
Caloric Restriction Mimetics as Priming Agents of Mesenchymal Stem Cells Secretome to Enhance Regenerative Responses to Parkinson’s Disease
Carneiro-Pereira, B., Ferreira-Antunes, F., Campos, J., Salgado, A. J., & Sampaio‐Marques, B. (2025) · Molecules · doi:10.3390/molecules30112260 · Cited by 6
Role of Cellular Senescence in Parkinson’s Disease: Potential for Disease-Modification Through Senotherapy
Rademacher, D. J., Exline, J. E., & Foecking, E. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061400 · Cited by 8
Decisive role of apurinic/apyrimidinic endonuclease/Ref-1 in initiation of cell death
Cho, K., Kim, H. J., Park, S. C., Kim, H., & Kim, G. W. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.07.001 · Cited by 6
Oxidative Stress in Parkinson’s Disease: Role in Neurodegeneration and Targets for Therapeutics
Banerjee, R., Kaidery, N. A., & Thomas, B. (2015) · ACS symposium series · doi:10.1021/bk-2015-1200.ch005 · Cited by 7
Toxin-Mediated Complex I Inhibition and Parkinson’s Disease
Miranda, B. R. D., Houten, B. V., & Sanders, L. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_6 · Cited by 6
On the key role played by altered protein conformation in Parkinson’s disease
Agnati, L. F., Baldelli, E., Andreoli, N., Woods, A. S., Vellani, V., Marcellino, D. J., Guidolin, D., & Fuxé, K. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0072-1 · Cited by 6
Editorial: apoptosis in the aging brain
Ziv, I., & Melamed, E. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0536-2 · Cited by 6
Organic electrolyte gated field effect transistor for detecting alpha synuclein longitudinally in Parkinsonism mouse model
Johri, S., Chan, D., Massey, R. S., Knight, D., DeRosa, M. C., Holahan, M. R., & Prakash, R. (2025) · npj Biosensing · doi:10.1038/s44328-025-00057-8 · Cited by 5
Modeling familial and sporadic Parkinson's disease in small fishes
Yamanaka, T., & Matsui, H. (2023) · Development Growth & Differentiation · doi:10.1111/dgd.12904 · Cited by 5
Current concepts on the etiology and pathogenesis of Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00005-6 · Cited by 5
α‐Synuclein ( SNCA ) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism
Sokratous, M., Breza, M., Senkevich, K. A., Gan‐Or, Z., Kalampokini, S., Spanaki, C., Provatas, A., Zaunmuktane, Z., Valotassiou, V. J., Georgoulias, P., et al. (2021) · Movement Disorders · doi:10.1002/mds.28735 · Cited by 5
References
Shaw, C. A. (2017) · Wiley eBooks · doi:10.1002/9781118634523.refs · Cited by 9
Engrailed 1 deficiency induces changes in ciliogenesis during human neuronal differentiation
Hembach, S., Schmidt, S. W., Orschmann, T., Burtscher, I., Lickert, H., Giesert, F., Weisenhorn, D. M. V., & Wurst, W. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106474 · Cited by 4
Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets
Sharma, Y., Gupta, J. K., Babu, M. A., Singh, S., & Sindhu, R. K. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02269-5 · Cited by 6
Primary components of MCT ketogenic diet are detrimental to bone loss associated with accelerated aging and age-related neurotoxicity in mice
Jain, S., & Vohora, D. (2024) · Bone · doi:10.1016/j.bone.2024.117383 · Cited by 4
Animal models of Parkinson’s disease and related disorders
Petzinger, G. M., & Jakowec, M. W. (2013) · CRC Press eBooks · doi:10.1201/b14361-17 · Cited by 4
Measuring Mitochondrial Dysfunction Caused by Soluble α-Synuclein Oligomers
Luth, E. S., & Stavrovskaya, I. G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9124-2_14 · Cited by 4
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease
Ferrucci, M., & Fornai, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_239-1 · Cited by 4
Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases
Legname, G., Virgilio, T., Bistaffa, E., Luca, C. M. G. D., Catania, M., Zago, P., Isopi, E., Campagnani, I., Tagliavini, F., Giaccone, G., et al. (2018) · Prion · doi:10.1080/19336896.2018.1464367 · Cited by 4
Transcription Factor as Therapeutic Targets for Neurodegenerative Disorders: An Update
Pal, R. (2018) · Modern Approaches in Drug Designing · doi:10.31031/madd.2018.01.000525 · Cited by 4
Mitochondrial protein import stress augments α-synuclein aggregation and neurodegeneration independent of bioenergeticsPreprint
Coyne, L. P., Rana, A., Wang, X., Bhagwagar, S. Z., Umino, Y., Solessio, E. C., Middleton, F. A., & Chen, X. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.20.508793 · Cited by 3
Targeting PI3K/Akt/mTOR with fisetin mechanistic and therapeutics insights for Parkinson’s disease
Barik, S. K., Bansal, R., & Singh, S. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100319 · Cited by 4
Proteasome localization and activity in pig brain and in vivo small molecule screening for activators
Almira, A. A., Chen, M. W., Demerdash, N. E., Javdan, C., Park, D., Lee, J. K., & Martin, L. J. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1353542 · Cited by 3
Self-citation
Alpha-synuclein in mitochondrial dysfunction: opportunities or obstacles
Gunawardena, S. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01966 · Cited by 3
Progress of p53 Involvement in Central Nervous System Diseases and Targeted Drug Discovery
Xu, F., Liu, Z., Wang, Z., Zhang, Y., Zhao, Y., & Fang, W. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70089 · Cited by 3
Can Adult Neurogenesis Be Considered as Neuroplasticity?
Famitafreshi, H., & Karimian, M. (2019) · Archives of Neuroscience · doi:10.5812/ans.79812 · Cited by 3
A Gravity-Fed Transcardial Perfusion Method for Histologic Analysis of the Mouse Central Nervous System
Rana, A., Massa, P. T., & Chen, X. J. (2022) · Journal of Visualized Experiments · doi:10.3791/63386 · Cited by 8
Plasma level of alpha-synuclein oligomers as a biomarker for isolated rapid eye movement sleep behavior disorder diagnosis and progression: a prospective cohort study
Chao, Y., Zhang, H., Wang, T., Li, Y., Mao, W., Hu, S., Zhao, L., & Cai, Y. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1442173 · Cited by 3
Oxidative stress in neurodegeneration: targeting mitochondria as a therapeutic aid
Gaggelli, E., & Valensin, G. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1001-0_12 · Cited by 3
Modeling synucleinopathies in rodents
Janer, A. B., Vonck, E., & Baekelandt, V. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.09.001 · Cited by 3
The neurobiology of the spinal cord in experimental parkinsonism and Parkinson's disease.
Ferrucci, M., Biagioni, F., Vivacqua, G., Busceti, C. L., Bartalucci, A., Soldani, P., D’Este, L., Fumagalli, L., & Fornai, F. (2013) · PubMed · Cited by 3
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modelling of Parkinson’s Disease
Pasquali, L., Ienco, E. C., & Fornai, F. (2014) · CINECA IRIS Institutial research information system (University of Pisa) · Cited by 3
ATPase Thorase Deficiency Causes α-Synucleinopathy and Parkinson’s Disease-like Behavior
Gao, F., Zhang, H., Yang, J., Cai, M.-H., Yang, Q., Wang, H.-S., Xu, Y., Chen, H., Hu, Y., He, W., et al. (2022) · Cells · doi:10.3390/cells11192990 · Cited by 3
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Ciceri, D., Gregorio-Zabala, L., Llama-Pino, X., Kurt, B., Olano-Bringas, J., Villegas‐Zafra, P., & Bengoa‐Vergniory, N. (2023) · Journal of Visualized Experiments · doi:10.3791/65453 · Cited by 2
Oxidative Stress in Parkinson's Disease; Parallels Between Current Animal Models, Human Studies and Cells
Norazit, A., Mellick, G. D., & Meedeniy, A. C. B. (2012) · InTech eBooks · doi:10.5772/33459 · Cited by 2
α-Synuclein and Parkinson's Disease
Gasser, T. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00003-9 · Cited by 2
Mitochondrial dysfunction in protein conformational disorders
Brielle, S., & Kaganovich, D. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0958-0 · Cited by 2
Dysfunction of mitochondria as the basis of Parkinson’s disease
Popis, M. (2018) · Medical Journal of Cell Biology · doi:10.2478/acb-2018-0027 · Cited by 2
Systematic interaction mapping reveals novel modifiers of neurodegenerative disease processes
Russ, J. (2012) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/16631 · Cited by 2
At the Intersection Between Mitochondrial Dysfunction and Lysosomal Autophagy: Role of PD-Related Neurotoxins and Gene Products
Asiago, J. M., Doyle, T. B., Mishra, V. R., Jacquet, A. D. R., & Rochet, J. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00325 · Cited by 1
Correlation between α-synuclein and fatty acid composition in jejunum of rotenone-treated mice is dependent on acyl chain length
Hajdúchová, D., Holič, R., Gajdoš, P., Čertík, M., Halášová, E., Péčová, R., & Pokusa, M. (2022) · General Physiology and Biophysics · doi:10.4149/gpb_2022046 · Cited by 1
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease
Ferrucci, M., & Fornai, F. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_239 · Cited by 1
The Neuroprotective and Antioxidant Activities of Spirulina
Bertolin, T. E., Guarienti, C., Frota, E. G., & Outeiro, T. F. (2024) · Springer eBooks · doi:10.1007/978-3-031-61253-4_7 · Cited by 1
Pharmacological Activity of Scopoletin: Deciphering the Potential of Coumarins in Cognitive Dysfunction
Wal, P., Vadera, S., Aziz, N., Gupta, P., Rajesh, K. S., Rao, C. M. P., & Sharma, M. C. (2025) · Current Drug Research Reviews · doi:10.2174/0125899775358899250726213130 · Cited by 1
Fc-Modified IVIG with Enhanced Blood–Brain Barrier Penetration Ameliorates Cognitive Deficits and Neuropathology in A53T α-Synuclein Transgenic Mice
Zhu, J., Huang, Y.-R., Wang, M., Liang, S.-Y., Yu, X.-L., Zhang, G., & Liu, R. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01626-1 · Cited by 1
mGluR4–NPDC1 complex mediates α-synuclein fibril-induced neurodegeneration
Pérez‐Cañamás, A., Chen, M., Almandoz-Gil, L., Khan, N., Tang, S. J., Ho, A., Gunther, E. C., & Strittmatter, S. M. (2025) · Nature Communications · doi:10.1038/s41467-025-67731-3 · Cited by 1
Research progress on employing medicinal plants and their active compounds to target autophagic pathways for Parkinson's disease therapy
Hu, W., Li, W. Y., Yang, A., Jiao, X., Zhang, A., Li, J., Zhao, L., Zhao, B., Wan, D., Zhang, X., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121574 · Cited by 1
Stimulated protein degradation to promote mitochondrial function and neuronal survival
Chandrasekhar, S., McMinimy, R. A., Manford, A. G., Wehri, E., Gee, C. L., Miller, C., Bingol, B., Kuriyan, J., Schaletzky, J., & Rapé, M. (2026) · Science · doi:10.1126/science.aed2525 · Cited by 1
Mitochondrial Fission-Fusion and Parkinson’s Disease: A Dynamic Question of Compensatory Networks
Chu, C. T., & Berman, S. (2011) · Springer eBooks · doi:10.1007/978-94-007-1291-1_7 · Cited by 1
Parkinson’s Disease: Insights from the Laboratory and Clinical Therapeutics
Zhou, J.-Y., Yu, Y., Zhu, X.-L., Ng, C.-P., Lü, G., & Poo, W.-S. (2012) · InTech eBooks · doi:10.5772/33092 · Cited by 1
Animal Models for PD and ALS
Kuenstling, M. V., Szlachetka, A. M., & Mosley, R. L. (2013) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4614-8794-4_34 · Cited by 1
The involvement of alpha-synuclein in parkinson’s disease
Karikari, T. K. (2014) · Cited by 1
Modeling synucleinopathies in genetically modified animals: Successes and failures
Ninkina, N. N., Ustyugov, A. A., & Buchman, V. L. (2008) · Molecular Biology · doi:10.1134/s0026893308050129 · Cited by 1
6Chapter Micronutrients for the Prevention of Diabetes and Improvement of the Standard Therapy
Prasad, K. N. (2010) · CRC Press eBooks · doi:10.1201/ebk1439821060-11 · Cited by 1
Bridging the gap between high-throughput genetic and transcriptional data reveals cellular pathways responding to alpha-synuclein toxicity
Yeger‐Lotem, E., Riva, L., Su, L. J., Gitler, A. D., Cashikar, A. G., King, O. D., Auluck, P. K., Geddie, M. L., Valastyan, J. S., Karger, D. R., et al. (2009) · Cited by 1
Autophagy and Proteostasis: A Unifying Theory of Neurodegenerative Disease
Novack, J. P. (2017) · Journal of Restorative Medicine · doi:10.14200/jrm.2017.6.0102 · Cited by 1
Role of Mitochondria and Oxidative Stress in Parkinson’s Disease
Santos, R. X., Correia, S. C., Cardoso, S., Carvalho, C., Candeias, E., Plácido, A. I., Duarte, A. I., Santos, M. S., & Moreira, P. I. (2014) · CRC Press eBooks · doi:10.1201/b16653-26 · Cited by 1
Neurodegeneration models in Drosophila
Roy, B., & Jackson, G. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9780511920585.012 · Cited by 1
Genetic Models of Familial Parkinson's Disease
Ying, M., Dawson, V. L., & Dawson, T. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00017-8 · Cited by 1
Micronutrients for the Prevention and Improvement of the Standard Therapy for Parkinson’s Disease
Prasad, K. N. (2019) · CRC Press eBooks · doi:10.1201/9780429243462-10 · Cited by 1
Preclinical models based on genetic mutations associated with the familial form of Parkinson's disease
Segura‐Aguilar, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822120-4.00009-5 · Cited by 1
Creating a protein-protein interaction network for alpha-synuclein
Könn, M. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7491 · Cited by 1
The cytoskeletal linker protein, Ezrin, inhibits α-synuclein fibrillization and toxicity by a novel mechanism
Shah, M. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-17133 · Cited by 1
The Effects of Oxidative Stress on Calcineurin Activity and DJ-1 Subcellular Localization
Diec, D. (2009) · TSpace (University of Toronto) · Cited by 1
Current Concepts on the Etiology and Pathogenesis of Parkinson Disease
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50008-5 · Cited by 1
Mitochondria
Cheville, N. F. (2009) · doi:10.1002/9780813810379.ch8 · Cited by 1
Enhanced mTORC1 signaling and Protein Synthesis in Parkinson’s Disease Pathogenesis Disease Pathogenesis
Khan, M. R., Yin, X., Kang, S.-U., Mitra, J., Wang, H., Brahmachari, S., Karuppagounder, S. S., Kimura, Y., Jhaldiyal, A., Kim, H. H., et al. (2022) · doi:10.1101/2022.10.03.510455
Zebrafish as a Model for the Study of Parkinson’s Disease
Xi, Y. (2011) · uO Research (University of Ottawa) · doi:10.20381/ruor-4585
Mitochondrial Involvement in Neurodegeneration and Aging
Pickrell, A. M. (2012)
Prospects for Neuroprotective Therapies that can Modulate Non‐Dopaminergic Features in Parkinson's Disease
Olanow, C. W., & Lang, A. E. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch39
Parkinson disease: identifying different players sharing a common principle
Farooqı, A. A., Arshad, S., Fayyaz, S., Abbas, S., & Bhatti, S. (2011) · Research in Biotechnology
Effects of Alpha-Synuclein on Cellular Homeostasis
Vekrellis, K., Minakaki, G., & Emmanouilidou, E. (2011) · InTech eBooks · doi:10.5772/17637

Authors: Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K.
Affiliations: Johns Hopkins University (US)
National Institutes of Health (US)
ORCID: Martin, Lee J.
Jenkins, Nancy A.
Lee, Michael K.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2006-01-04
Volume: 26
Issue: 1
Pages: 41-50
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.4308-05.2006
PMC: PMC6381830
OpenAlex: W2084910880
Cited by: 684
References: 59
Citations by year: 2026: 15 · 2025: 14 · 2024: 24 · 2023: 27 · 2022: 37 · 2021: 34 · 2020: 27 · 2019: 34 · 2018: 39 · 2017: 43 · 2016: 34 · 2015: 30 · 2014: 35 · 2013: 41 · 2012: 49
FWCI: 26.91
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-sa
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 181 d)
Locations: Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (NS38377)
U.S. Public Health Service
National Institute on Aging (AG 16282, R01AG016282)
National Institute of Neurological Disorders and Stroke (NS 38377, R01NS052098, NS34 100, P01NS038065, R56NS038065, P50NS038377, NS 38065, R01NS034100, R01NS038065, NS52098)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: alpha-synuclein, Parkinson's disease, A53T mutation, A30P mutation, transgenic mice, mitochondrial degeneration, neuronal cell death, motor neuron degeneration, axonal degeneration, Lewy bodies, mitochondrial DNA damage, apoptosis, caspase-3, p53, mitochondrial complex IV, synucleinopathies
MeSH terms: Alanine, Animals, Brain Stem, DNA Damage, Humans, Mice, Transgenic, Mitochondria, Mutation, Nerve Degeneration, Parkinson Disease, Threonine, Cell Death, Neocortex, Mice, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks